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The present study is to prepare and evaluate controlled release matrix tablets of 
Losartan potassium using natural and synthetic polymers. Tablets were prepared by direct 
compression method using different drug: polymer concentration. Fourier Transform 
Infrared Spectroscopy (FT-IR) and Differential Scanning Calorimetry (DSC) study revealed 
no chemical interaction between drug and polymers used. Precompression and 
postcompression parameters complied with pharmacopoeial limit for the tablets. In-vitro 
release studies was performed and the results indicates that matrix tablet (F9)  containing 
50% w/w blend of  natural and synthetic polymer has better controlled release for a period of 
24 h. 
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Controlled release dosage form covers a 
wide range of prolonged action formulations 
which provides continuous release of their 
active ingredients at a predetermined rate 
and for a predetermined time. The majority of 
these formulations are designed for oral 
administration. The most important objective 
for the development of these systems is to 
furnish an extended duration of action and 
thus assure greater patient compliance. 
Losartan potassium (Johnston 1995) is widely 
used in the treatment of hypertension, delay 
progression of diabetic nephropathy and is 
also indicated for the reduction of renal 
disease progression in patients with type 2 
diabetes (en.wikipedia.org/wiki/ losartan 
_potassium 2011), and microalbuminuria (>30 
mg/24 h) or proteinuria (>900 mg/24 h). 
Developing oral controlled release matrix 
tablets for highly water soluble drugs with 
constant release rate has always been a 
challenge to the pharmaceutical technologist. 
Hydrophilic polymers are becoming very 
popular in formulating oral controlled release 
tablets (Sundaramoorthy 2008). As the fluid 
or media penetrates the matrix tablet, the 
polymer swells and drug diffuses from the 
system at a rate determined by nature and 
composition of polymer. A hydrophilic 
polymer from synthetic origin such as 
Hydroxy propyl methyl cellulose K4M 
(HPMC K4M) and from natural origin such as 
xanthan gum was used to develop controlled 
release matrix tablets of losartan potassium. 
Tablets were prepared by direct compression 
with alone and combination of polymers. 
 
Materials and Methods 
Losartan potassium was a gift sample 
from M/S Vijashree chemicals. Pvt. Ltd. 
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Hyderabad, Hydroxypropylmethylcellulose 
K4M (HPMC K4M) was a gift sample from 
Colorcon. Ltd. Goa, Xanthan gum (XG) was a 
gift sample from Krystal colloid Ltd. 
Mumbai, Microcrystalline cellulose (MCC) 
and Polyvinyl pyrolidone were gift samples 
from S.D. Fine. Pvt. Ltd. Mumbai and all the 
other chemicals used in the formulations 
were of analyltical grade. 
 
Preparation of Losartan potassium matrix 
tablets 
 The controlled release matrix tablets of 
losartan potassium were prepared by the 
direct compression method. The drug, 
polymers and other excipients (batch size 50 
tablets) were passed through sieve # 80. The 
controlled release tablets containing drug, 
matrix materials, diluents, binder and 
lubricants were mixed uniformly and 
compressed on 10 station tablet machine 
using 8 mm round and flat punches with 
hardness between 5-7 kg cm-2 (Table 1). 
 
Preformulation studies of losartan 
potassium 
FTIR study 
The compatibility between drug and 
polymers was detected by IR spectra obtained 
on Shimadzu 8400, Japan. The pellets were 
prepared on KBr- press (startech lab, India). 
The spectra were recorded over the wave 
number range of 4000 to 500 cm-1 (Fig 1). 
 
Table 1. Composition of Losartan potassium matrix tablets 
INGREDIENTS (mg) F1 F2 F3 F4 F5 F6 F7 F8 F9 
Losartan potassium 80 80 80 80 80 80 80 80 80 
XG 160 180 200 - - - 80 90 100 
HPMC K4M - - - 160 180 200 80 90 100 
MCC 132 112 92 132 112 92 132 112 92 
PVP 20 20 20 20 20 20 20 20 20 
Talc 4 4 4 4 4 4 4 4 4 
Magnesium Stearate 4 4 4 4 4 4 4 4 4 
Total 400 400 400 400 400 400 400 400 400 
 
 
Fig 1. FT-IR spectra of Plane losartan potassium and F-9. 
 
DSC study 
 Further the compatibility between 
drug and polymer was detected by DSC 
study. Thermograms were obtained by using 
a differential scanning calorimeter 
(NETZSCH, DSC 200PC, Japan) at a heating 
rate 10o C/min over a temperature range of 
35-250o C. The sample was hermetically 
sealed in an aluminium crucible. Nitrogen 
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gas was purged at the rate of 10 ml/ min for 
maintaining inert atmospheres (Fig 2).   
Identification 
The drug was identified by the light 
absorption in the U.V. range of 200-400 nm. 
The absorbance’s of drug solutions were 0.557 
and 0.432 respectively for pH 1.2 and pH 6.8 
at λmax 205.0 nm. This was in accordance 
with reported values (Table 2). 
 
 
Fig 2. DSC thermo gram of Plane losartan potassium and F-9. 
Solubility 
 The available literature on solubility 
profile of losartan potassium indicated that 
the drug is freely soluble in water and 
slightly soluble in acetonitrile. The results of 
losartan potassium solubility in various 
media are shown in the (Table 3). 
Angle of repose 
Angle of repose was determined using 
fixed funnel method. A glass funnel is held in 
place with a clamp on a ring support over a 
glass plate. Approximately 1 gm of powder is 
transferred into funnel keeping the orifice of 
the funnel blocked by the thumb. When the 
powder is emptied from funnel, the angle of 
the heap to the horizontal plane is measured. 
Angle of repose (θ) = tan-1 (h/r) 
Carr’s index 
Based on the apparent bulk density 
and the tapped density, the percentage 
compressibility of the powder mixture was 
determined by the following formula. 
                            Tapped density - Bulk density 
 Carr’s index   =                                        X 100 
                                 Tapped density 
Hausner’s ratio 
Hausner ratio is an indirect index of ease 
of measuring the powder flow (Cooper 
1986). It is calculated by the following 
formula.    
     Tapped density 
     Hausner’s ratio =                 
                                               Bulk density 
Lower hausner ratio (<1.25) indicates better 
flow properties than higher ones (>1.25). 
Precompressional parameters are given in 
Table 4. 
Table 2. Calibration curve for the estimation of 
losartan potassium in pH 1.2 and 6.8. 
Concentration 
µg/ml 
Absorbance* 
pH 1.2 pH 6.8 
0.0 0.0 0.0 
3 0.132 0.096 
6 0.234 0.178 
9 0.331 0.275 
12 0.443 0.341 
15 0.557 0.432 
18 0.644 0.529 
21 0.747 0.620 
24 0.871 0.714 
27 0.972 0.810 
               *Average of three determinations 
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Table 3. Solubility study of losartan potassium 
 Solubility (gm/ml)* 
Studies pH 1.2  
(0.1 N HCl) 
pH 6.8  
(Phosphate
buffer) 
pH 7.0 
(Water) 
Result 1.372 1.289 1.230 
*Average of 3 determination. 
 
Hardness 
 Monsanto hardness tester was used for 
the determination of the hardness.  The tablet 
to be tested was held between a fixed and a 
moving jaw and reading of the indicator 
adjusted to zero. The force applied to the 
edge of the tablet is gradually increased by 
moving the screw knob forward until the 
tablet breaks. The reading is noted from the 
scale which indicates the pressure required in 
kg or lb to break tablets. 
Weight variation 
 Weight variation study was carried out 
as per USP. Twenty tablets were randomly 
selected from each batch weighed 
individually (USP 2000). The average weight 
and standard deviation was calculated. 
Table 4. Micromeritic properties of precompressional powder blend. 
Formulation 
code 
Angle of 
repose 
(θ) 
Carr’s 
index  
(%) 
Hausner’s 
ratio 
 
LP 41.22 ± 0.16 31.19 ± 0.14 1.45 ± 0.07 
F1 17.66 ± 0.32 18.25 ± 0.09 1.22 ± 0.02 
F2 18.41 ± 0.15 19.37 ± 0.02 1.24 ± 0.01 
F3 19.33 ± 0.87 18.05 ± 0.14 1.22 ± 0.02 
F4 21.32 ± 0.41 17.90 ± 0.11 1.21 ± 0.03 
F5 23.31 ± 1.27 19.12 ± 0.30 1.23 ± 0.01 
F6 24.56 ± 3.01 17.46 ± 0.21 1.21 ± 0.03 
F7 26.10 ± 0.94 19.72 ± 0.18 1.24 ± 0.01 
F8 27.14 ± 1.44 16.95 ± 0.21 1.20 ± 0.03 
F9 29.31 ± 2.41 19.09 ± 0.13 1.23 ± 0.01 
All values are expressed as mean ± SD, n=3. 
Table 5. Evaluation of different matrix tablets of losartan potassium 
Formulation 
code 
Hardness+ 
(kg/cm2) 
Friability† 
(%) 
Thickness† 
(mm) 
Drug content+ 
(%) 
Weight 
variation* 
(%) 
F1 5.46 ± 0.18 0.31 ± 0.09 4.07 ± 0.08 98.21 ± 0.33 2.33 ± 0.01 
F2 5.48 ± 0.06 0.28 ± 0.08 4.02 ± 0.04 98.01 ± 0.26 1.72 ± 0.32 
F3 5.71 ± 0.48 0.22 ± 0.05 3.97 ± 0.05 98.45 ± 0.14 1.38 ± 0.16 
F4 5.64 ± 0.38 0.34 ± 0.07 3.94 ± 0.08 98.32 ± 0.17 1.22 ± 0.11 
F5 5.71 ± 0.32 0.32 ± 0.06 4.05 ± 0.04 98.41 ± 0.11 1.71 ± 0.37 
F6 5.63 ± 0.44 0.29 ± 0.03 4.08 ± 0.06 98.11 ± 0.24 2.37 ± 0.12 
F7 6.06 ± 0.32 0.35 ± 0.08 3.93 ± 0.05 99.32 ± 0.14 1.62 ± 0.43 
F8 6.42 ± 0.34 0.33 ± 0.05 4.05 ± 0.05 98.52 ± 0.22 1.41 ± 0.33 
F9 6.56 ± 0.53 0.29 ± 0.04 3.99 ± 0.04 99.93 ± 0.13 1.73 ± 0.69 
All values are expressed as mean ± SD, n = 5+, 10†, 20*. 
Mohd Azharuddin et al. / Research in Biotechnology, 2(4): 26-32, 2011 
 
30 
 
 
Post compressional studies of the prepared 
matrix tablet 
Uniformity of thickness 
 The crown-to-crown thickness of ten 
tablets from each batch was determined using 
micrometer calipers. The thickness variation 
limits allowed are ± 5% of the size of the 
tablet. 
 
Friability 
 Friability of the tablets was determined 
using Roche friabilator (Electrolab, Mumbai). 
This device subjects the tablets to the 
combined effect of abrasions and shock in a 
plastic chamber revolving at 25 rpm and 
dropping the tablets at a height of 6 inches in 
each revolution (USP 2000). Preweighed 
sample of tablets was placed in the friabilator 
and were subjected to 100 revolutions. Tablets 
were degusted using a soft muslin cloth and 
reweighed. The friability (F) is given by the 
formula:   
                F = (1- W0 / W) × 100 
Where, W0 is the weight of the tablets before 
the test and W is the weight of the tablet after 
the test  
 
Drug content 
 For determination of drug content at 
least five tablets from each formulation were 
weighed individually, crushed and diluted to 
100 ml with sufficient amount of phosphate 
buffer of pH 6.8 (USP 2000). Then aliquot of 
the filtrate was diluted suitably and analyzed 
spectrophotometrically at 205 nm against 
blank. Drug content was calculated using 
standard curve. All parameters of post 
compressional studies of the prepared matrix 
tablet presented in Table 5. 
 
Dissolution studies 
 The prepared matrix tablets were 
subjected to in-vitro dissolution studies using 
an 8 station USP dissolution apparatus 
(Electro Lab, TDT-08L, Mumbai). The 
dissolution studies were carried out in pH 1.2 
for 2 hrs & in pH 6.8 for next 22 hrs at 37 ± 
0.50 c and 100 rpm. At regular time interval, 5 
ml of sample was withdrawn from the 
dissolution medium and replaced with equal 
volume of fresh medium (Deshmukh 2009). 
After filtration and appropriate dilution, the 
samples were analyzed at 205 nm for losartan 
potassium against blank using UV-Visible 
spectrophotometer. The amount of drug 
present in the samples was calculated using 
standard curve (Fig 3, 4 and 5) 
 
 
Fig 3. Effect of polymer level on in-vitro 
release of losartan potassium from XG 
matrix tablets. 
 
 
Fig 4. Effect of polymer level on in-vitro 
release of losartan potassium from HPMC 
K4M matrix tablets. 
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Fig 5. Effect of polymer level on in-vitro 
release of losartan potassium from XG - 
HPMC K4M matrix tablets.  
 
Results and Discussion 
 In the present study FT-IR data of the 
formulation was compared with the standard 
spectrum of pure drug losartan potassium 
and the characteristic peaks associated with 
specific functional groups and bonds of the 
molecule and their presence/absence in the 
polymeric carrier (formulation) were noted. 
The IR spectrum of the formulation F9 
showed that there is no significant evidence 
for interaction between drug and the 
polymer. The DSC thermogram revealed that 
there is no any appreciable change in the 
nature of the melting endotherms suggesting 
that the drug has not lost its characteristic 
properties even in its formulation form as 
there is no interaction of the drug with the 
polymer and other excipients used for the 
study. Plain losartan potassium exhibited 
angle of repose value of 41.22 ± 0.16o 
indicating poor flow property. It was further 
supported by high Carr’s index (31.19 ± 0.14) 
and Hausner’s ratio (1.45 ± 0.07). Hence it 
was necessary to use directly compressible 
vehicles like MCC to improve the flow 
property of losartan potassium. Very good 
flow property was observed with MCC and 
lubricants. The tablets of different batches of 
xanthan gum and HPMC K4M alone and in 
combination were found uniform with 
respect to thickness (3.93 to 4.08 mm), 
hardness (5.46 to 6.56 kg/cm2) and friability 
(0.22 to 0.35 %) indicating good handling 
property of the prepared matrix tablets. 
Weight variation (1.22 to 2.37%) and drug 
content (98.01 to 99.93%) were within 
prescribed pharmacopoeial limits. 
Dissolution study of all the formulations was 
carried out using    0.1 N HCl pH 1.2 for 2 h 
and in phosphate buffer pH 6.8 upto 24 h 
(Yeole 2006). Formulations F1 to F3 were 
prepared by using xanthan gum of 40%, 45% 
and 50%w/w and F4 to F6 were prepared by 
using HPMC K4M of 40%, 45% and 50%w/w 
of tables respectively. Formulation F7 to F9 
was prepared with polymer blend of xanthan 
gum and HPMC K4M (1:1) using different 
concentrations like 40%, 45% and 50% w/w 
of tablet. Among all these formulation F9 has 
shown the controlled release of drug for 24 h. 
The controlled drug release is due to 
increased proportion of polymers. 
 
Conclusion  
Results of the present research study 
confirmed that the polymer concentration 
plays a major role in drug release. As the 
polymer concentration of the tablets 
increased the drug release was prolonged in a 
controlled manner. 
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